Treatment of patients with chemotherapy induced anaemia Silapo should be administered by the subcutaneous route to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dl (6.2 mmol/l).
Aneemiaga patsientidele tuleb manustada Silapot naha alla (nt hemoglobiini kontsentratsioon ≤ 10 g/ dl (6, 2 mmol/ l).